Auto-Chlor System LLC made hand sanitizer under poor manufacturing practices and sold it as an unapproved, misbranded new drug.
What happened
FDA inspected Auto-Chlor’s drug manufacturing facility in Hapeville, GA, from July 5 to 18, 2022. FDA found violations of current good manufacturing practice (CGMP, the rules for drug manufacturing), including equipment shared with industrial cleaners, no testing of ethanol for methanol, no process validation, and weak quality oversight. FDA also reviewed the HAND KLEEN label and found the hand sanitizer was an unapproved new drug and misbranded.
What FDA found
The company did not have or follow written procedures for cleaning and maintaining equipment, and FDA observed inadequate cleaning of drug equipment also used for industrial cleaners.
21 CFR 211.67(b)The company did not test incoming components for identity and quality, including testing ethanol for methanol, and relied on certificates from unqualified suppliers.
21 CFR 211.84(d)(1) and (2)The company used (b)(4) water in drug products without testing it or showing it met purified water and microbial limits.
21 CFR 211.84(d)(1) and (2)The company had not validated its hand sanitizer manufacturing processes or qualified its equipment.
21 CFR 211.100(a)The quality unit failed to oversee training, active ingredient and microbial testing, stability, annual product reviews, batch records, and investigations.
21 CFR 211.22HAND KLEEN is an unapproved new drug and misbranded because its benzethonium chloride formula and labeling do not fit the OTC rules for consumer antiseptic rubs or washes.
FD&C Act sections 505(a), 502(ee), and 301(d)
What FDA wants
FDA tells Auto-Chlor to correct the violations promptly and respond in writing within 15 working days with what it has done and how it will prevent recurrence; if more time is needed, it must give reasons and a completion schedule. FDA also recommends a qualified CGMP consultant and says to notify FDA before resuming or outsourcing drug manufacturing.
Who should pay attention
- brands or distributors selling Auto-Chlor hand sanitizer
- contract manufacturers and private-label firms making OTC hand sanitizers
- companies sharing equipment between drug and industrial products
This is a summary. Read the original letter on fda.gov.